Skip to main content
D.Western Therapeutics Institute, Inc. logo

D.Western Therapeutics Institute, Inc. — Investor Relations & Filings

Ticker · 4576 ISIN · JP3548740004 T Professional, scientific and technical activities
Open in API
Filings indexed 69 across all filing types
Latest filing 2026-03-27 Share Issue/Capital Cha…
Country JP Japan
Listing T 4576

About D.Western Therapeutics Institute, Inc.

https://dwti.co.jp/english/

D.Western Therapeutics Institute, Inc. is a biotechnology company focused on the research, discovery, and development of innovative pharmaceutical drugs. The company's core technology is centered on a proprietary compound library with a primary focus on inhibitors, particularly protein kinase inhibitors. Its drug discovery and development business aims to provide patients with more effective and beneficial treatments than conventional drugs. A notable product developed from its research is the ophthalmic solution GLANATEC.

Recent filings

Filing Released Lang Actions
訂正有価証券届出書（組込方式）
Share Issue/Capital Change Classification · 1% confidence The document is a Japanese corrected securities registration statement (有価証券届出書) for a third‐party allotment of 2,150,500 new shares, detailing issuance price, capital increase, allotment conditions, and usage of proceeds. This is not a high‐level annual or interim report, nor an earnings release or management change notice. It is a full prospectus for a share issuance, matching the definition of “Share Issue/Capital Change” (SHA).
2026-03-27 Japanese
有価証券届出書（組込方式）
Share Issue/Capital Change Classification · 1% confidence The document is a Japanese Securities Registration Statement (“有価証券届出書”) filed on March 25, 2026, detailing a third‐party allotment of new shares (number of shares, issue price, capital increase, underwriter details, use of proceeds, dilution impact, and related agreements). It is a full filing concerning the issuance of new equity (capital change), not simply an announcement or investor presentation. This aligns precisely with the Share Issue/Capital Change category (SHA).
2026-03-25 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and is submitted under the Financial Instruments and Exchange Act. It serves as an officer certification by the President of D.Western Therapeutics Institute, Inc., confirming the accuracy of the Annual Securities Report (有価証券報告書) for the 28th fiscal period. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS). FY 28
2026-03-23 Japanese
有価証券報告書－第28期(2025/01/01－2025/12/31)
Annual Report Classification · 1% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It includes a cover page with the filing date (2026-03-23), the fiscal period (2025-01-01 to 2025-12-31), and detailed financial tables (consolidated and non-consolidated). It is not an announcement or a summary, but the full report itself. FY 2025
2026-03-23 Japanese
半期報告書－第28期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-annual Report) for the period ending June 30, 2025, filed by D.Western Therapeutics Institute, Inc. It contains comprehensive financial statements (Balance Sheet, Income Statement, Cash Flow Statement) and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, specifically related to the 'Second Quarter Report' (第２四半期報告書). It serves as a formal certification of the accuracy of the interim financial reporting period (Jan 1, 2025 to June 30, 2025). Since it is a regulatory filing required by law to accompany the interim report and does not fit into the specific categories of the report itself or other specialized categories, it is classified as a Regulatory Filing.
2025-08-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.